Announcement
14 Aug 2013
In August 2013, the South African Minister of Trade signed a new tax allowance for Moxisign to manufacture API and API biological peptides. This deal falls under section 12I of South Africa's Income Tax Act.
Source
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
Implementation date
14 Aug 2013
Revocation date:
No revocation date
On 14 August 2013, the South African Minister of Trade signed a new deal that allowed for Moxisign R853,364,548 in tax breaks to be spent on investments and personnel training related to the manufa...
See all
This state act is not part of any Thread yet.